Effect of access to prescribed PCSK9 inhibitors on cardiovascular outcomes KD Myers, N Farboodi, M Mwamburi, W Howard, D Staszak, S Gidding, ... Circulation: Cardiovascular Quality and Outcomes 12 (8), e005404, 2019 | 70 | 2019 |
A clinic‐based screening of mutations in exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's disease patients S Shojaee, F Sina, N Farboodi, Z Fazlali, F Ghazavi, SA Ghorashi, ... Movement Disorders 24 (7), 1023-1027, 2009 | 31 | 2009 |
Clinical spectrum in multiple families with primary COQ10 deficiency SS Hashemi, D Zare‐Abdollahi, MK Bakhshandeh, A Vafaee, ... American Journal of Medical Genetics Part A 185 (2), 440-452, 2021 | 22 | 2021 |
The second family affected with a PRDM8-related disease A Davarzani, A Shahrokhi, SS Hashemi, A Ghasemi, ... Neurological Sciences, 1-9, 2022 | 8 | 2022 |
A case of adult onset Sandhoff disease that mimics Brown-Vialetto-Van Laere syndrome M Khani, H Shamshiri, H Moazzeni, H Taheri, H Ahmadieh, A Alavi, ... Neuromuscular Disorders 31 (6), 528-531, 2021 | 1 | 2021 |
Identification of DHR96 Target Genes N Farboodi University of Alberta, 2011 | | 2011 |